Peeters, H. R., Jongen-Lavrencic, M., Vreugdenhil, G., & Swaak, A. J. (1996). Effect of recombinant human erythropoietin on anaemia and disease activity in patients with rheumatoid arthritis and anaemia of chronic disease: A randomised placebo controlled double blind 52 weeks clinical trial.
Chicago Style CitationPeeters, H R., M. Jongen-Lavrencic, G. Vreugdenhil, i A J. Swaak. Effect of Recombinant Human Erythropoietin On Anaemia and Disease Activity in Patients With Rheumatoid Arthritis and Anaemia of Chronic Disease: A Randomised Placebo Controlled Double Blind 52 Weeks Clinical Trial. 1996.
Cita MLAPeeters, H R., M. Jongen-Lavrencic, G. Vreugdenhil, i A J. Swaak. Effect of Recombinant Human Erythropoietin On Anaemia and Disease Activity in Patients With Rheumatoid Arthritis and Anaemia of Chronic Disease: A Randomised Placebo Controlled Double Blind 52 Weeks Clinical Trial. 1996.